Refining the level for anticipated hepatotoxicity in acetaminophen poisoning.
Treatment of an acetaminophen overdose with N-acetyl cysteine usually is based on the position of the 4-h acetaminophen (APAP) level on the Rumack-Matthew nomogram; however, there is disagreement on the level at which clinically relevant hepatotoxicity occurs. A retrospective review of all acute adult formulation APAP exposures reported to our poison center between 1986 and 1993 was performed and cases corresponding to the "possible risk or toxicity" range on the nomogram were identified. Our current poison center protocol for APAP poisoning does not recommend treatment with N-acetylcysteine (NAC) in low-risk patients if the 4-h serum APAP level or the extrapolated equivalent falls within the possible toxicity range on the nomogram. Seventeen cases met the inclusion criteria for the study and received no NAC; six additional patients met inclusion criteria but received one or two doses of NAC before therapy was discontinued. No patients in either group demonstrated clinical evidence of hepatotoxicity. This pilot study suggests that patients with no risk factors and APAP levels in the "possible risk" range may not require NAC therapy.
Brandwene
E L
EL
UCSD Medical Center 92103-8676, USA.
Williams
S R
SR
Tunget-Johnson
C
C
Turchen
S G
SG
Manoguerra
A S
AS
Clark
R F
RF
D000082:Acetaminophen / Q000506:poisoning* / Q000633:toxicity; D000111:Acetylcysteine / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D002985:Clinical Protocols; D062787:Drug Overdose / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D008099:Liver / Q000187:drug effects*; D008297:Male; D010865:Pilot Projects; D012189:Retrospective Studies; D013997:Time Factors
D000082:Acetaminophen; D000111:Acetylcysteine